Multiple facial lentigines can be dis®guring and can have a big impact on quality of life. In patients with dark skin, treatment options are especially limited.
CASE HISTORY
A 35-year-old Afro-Caribbean woman sought advice about the multiple small hyperpigmented macules on her face, limbs and trunk. She was distressed by her facial appearance and was reluctant to leave her house without heavy camou¯age make-up. The dark brown macules had started to appear on her face at the age of 11 and had gradually involved her lips and ears, sparing the mucous membranes. There was a strong family history of this pigment abnormality, with her father, brother and one half-sister similarly affected and her other half-brother and half-sister having only facial lentigines ( Figure 1 ). On examination she had numerous darkly pigmented macules on the face, lips, ears, neck, chest, shoulders, hands, buttocks and thighs. There was no mucous membrane involvement. Her electrocardiogram and echocardiogram were normal. A skin biopsy showed prominent basal hyperpigmentation but no increase in the number of melanocytes. These are characteristics of an ephelid (freckle) rather then a lentigo; however, the symmetrical distribution of the lesions on both sun-exposed and non-sun-exposed areas, and their lack of seasonal variability, was more in favour of lentigines. Satisfactory results were obtained with a test treatment with the Q-switched ruby laser (QSRL) to the lentigines on a small area of her left cheek. Subsequently her facial lesions were treated with QSRL at an energy of 5 J. After four treatment sessions at intervals of six weeks, the appearance of the face was much improved ( Figure 2 ). Over the past seven months there has been no recurrence of the treated lesions and in particular there is no epidermal atrophy, hypopigmentation or reactive hyperpigmentation in the treated areas.
COMMENT
The term lentiginosis is applied to conditions in which lentigines are present in exceptionally large numbers or in a distinctive distribution. There are several pigmentary patterns of lentiginosis and some may be associated with internal abnormalities. The best known of these is the 240 Our patient has all the features of the described inherited patterned lentiginosis in blacks.
The QSRL emits light with a wavelength of 694 nm, which is strongly absorbed by melanin and can destroy benign pigmented lesions by selective photothermolysis 2 . However, pigmented lesions in patients with dark skin are particularly dif®cult to treat because of the risk of producing hypopigmentation or reactive hyperpigmentation, which may be more prominent than the original lesion. Our patient had a good response to a test treatment at energies of 5.5 J and 7.5 J and further successful treatment with 5 J to the symmetrical parts of the face. We suggest that patients with coloured skin should not be discouraged from having laser treatment, though a test treatment should be done ®rst. In a patient with recurrent attacks of muscular weakness, the ®rst diagnosis that springs to mind is familial periodic paralysis. But the function of the thyroid gland deserves thought.
Paralysis after a diarrhoeal illness

CASE HISTORY
A female Asian student aged 26, domiciled in the UK since childhood, returned from a two-week Mediterranean holiday feeling unwell. After three days of profuse diarrhoea, lethargy and heat intolerance she required admission to hospital. Four months previously she had missed an appointment to a hospital clinic where she was being treated with carbimazole and thyroxine for Graves' thyrotoxicosis. A month before the current admission she had run out of medication. She also had a history of asthma, well controlled with inhaled beclomethasone and salbutamol.
At the time of admission, blood pressure was 110/60 mmHg, heart rate 120/min. She had moderate¯accid proximal muscle weakness, worse in the lower limbs; the rest of the clinical examination was unremarkable. Laboratory results at this stage were: plasma sodium 140 mmol/L, potassium 2.1 mmol/L, urea 7.2 mmol/L and creatinine 100 mmol/L; haemoglobin was 13.2 g/dL and white cell count 9.6610 9 /L, repeated stool examination and cultures were negative, as were blood cultures; liver function tests were normal. Thyroid function tests were: thyroxine (FT4), 54.2 pmol/L (normal 9.8±23.1), tri-idiothyronine (FT3) 30.2 pmol/L (3.50±6.5), thyrotropin (TSH)50.02 mU/L (0.35±5.50), TSH receptor antibodies 34% (510), thyroid peroxidase antibody 88 kU/L (518.0). She was managed with potassium supplements, intravenous¯uids and carbimazole 40 mg daily. On discharge four days later her muscle weakness had resolved and plasma potassium was 4.2mmol/L. Her antithyroid medication was continued at the same dose. Four weeks after discharge she was readmitted complaining of leg weakness of two hours' duration. The pattern of proximal muscle weakness was as before. Plasma potassium was 2.4 mmol/L and the electrocardiogram showed¯at T waves; FT4 was 27.2 pmol/L, FT3 8.5 pmol/L and TSH50.02 mU/L. Hypokalaemia was corrected with potassium supplements, the muscle weakness improved and she was discharged after ®ve days. At an outpatient clinic two weeks later she had no apparent muscular weakness, plasma potassium was 4.2 mmol/L and she was euthyroid (FT4 14.0 pmol/L, TSH 0.5 mU/l). Thyroxine 100 mg daily was added to her medication.
